We evaluate bevacizumab, a monoclonal antibody, expression in time course from mRNA transient transfection in CHO cells using MS. We transiently transfected bevacizumab heavy and light chain mRNAs into CHO-S WT using lipoplex. Later, we analysed the bevacizumab protein intracellularly.